These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27689756)

  • 1. Evaluation of antidepressant-like and anxiolytic-like activity of purinedione-derivatives with affinity for adenosine A
    Dziubina A; Szmyd K; Zygmunt M; Sapa J; Dudek M; Filipek B; Drabczyńska A; Załuski M; Pytka K; Kieć-Kononowicz K
    Pharmacol Rep; 2016 Dec; 68(6):1285-1292. PubMed ID: 27689756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A2A receptors and depression.
    El Yacoubi M; Costentin J; Vaugeois JM
    Neurology; 2003 Dec; 61(11 Suppl 6):S82-7. PubMed ID: 14663017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
    Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
    Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa).
    Zhang LM; Zhao N; Guo WZ; Jin ZL; Qiu ZK; Chen HX; Xue R; Zhang YZ; Yang RF; Li YF
    Neuropharmacology; 2014 Jun; 81():116-25. PubMed ID: 24067925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A
    Poleszak E; Szopa A; Bogatko K; Wyska E; Wośko S; Świąder K; Doboszewska U; Wlaź A; Wróbel A; Wlaź P; Serefko A
    Neurotox Res; 2019 Feb; 35(2):344-352. PubMed ID: 30267268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.
    El Yacoubi M; Ledent C; Parmentier M; Bertorelli R; Ongini E; Costentin J; Vaugeois JM
    Br J Pharmacol; 2001 Sep; 134(1):68-77. PubMed ID: 11522598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfur dioxide derivatives produce antidepressant- and anxiolytic-like effects in mice.
    Shi X; Gao Y; Song L; Zhao P; Zhang Y; Ding Y; Sun R; Du Y; Gong M; Gao Q; Shi Y; Guo Q; Shi H
    Neuropharmacology; 2020 Oct; 176():108252. PubMed ID: 32712276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
    Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
    Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for new potential anticonvulsants with anxiolytic and antidepressant properties among derivatives of 4,4-diphenylpyrrolidin-2-one.
    Malawska K; Rak A; Gryzło B; Sałat K; Michałowska M; Żmudzka E; Lodarski K; Malawska B; Kulig K
    Pharmacol Rep; 2017 Feb; 69(1):105-111. PubMed ID: 27915183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
    Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
    Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant- and anxiolytic-like activity of magnesium in mice.
    Poleszak E; Szewczyk B; Kedzierska E; Wlaź P; Pilc A; Nowak G
    Pharmacol Biochem Behav; 2004 May; 78(1):7-12. PubMed ID: 15159129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats.
    Kaminska K; Rogoz Z
    J Physiol Pharmacol; 2016 Jun; 67(3):471-80. PubMed ID: 27512008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450.
    Chaki S; Nakazato A; Kennis L; Nakamura M; Mackie C; Sugiura M; Vinken P; Ashton D; Langlois X; Steckler T
    Eur J Pharmacol; 2004 Feb; 485(1-3):145-58. PubMed ID: 14757135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
    Hughes ZA; Liu F; Platt BJ; Dwyer JM; Pulicicchio CM; Zhang G; Schechter LE; Rosenzweig-Lipson S; Day M
    Neuropharmacology; 2008 Jun; 54(7):1136-42. PubMed ID: 18423777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GABAB receptor ligands in animal tests of depression and anxiety.
    Frankowska M; Filip M; Przegaliński E
    Pharmacol Rep; 2007; 59(6):645-55. PubMed ID: 18195453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of metabolic stability and the cell permeability of 2-pyrimidinyl-piperazinyl-alkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione with antidepressant- and anxiolytic-like activities.
    Zagórska A; Partyka A; Bucki A; Kołaczkowski M; Jastrzębska-Więsek M; Czopek A; Siwek A; Głuch-Lutwin M; Bednarski M; Bajda M; Jończyk J; Piska K; Koczurkiewicz P; Wesołowska A; Pawłowski M
    Chem Biol Drug Des; 2019 Apr; 93(4):511-521. PubMed ID: 30422400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of antidepressant-like and anxiolytic-like actions and cognitive and motor side effects of four N-methyl-D-aspartate receptor antagonists in mice.
    Refsgaard LK; Pickering DS; Andreasen JT
    Behav Pharmacol; 2017 Feb; 28(1):37-47. PubMed ID: 27740963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenon produces rapid antidepressant- and anxiolytic-like effects in lipopolysaccharide-induced depression mice model.
    Shao J; Meng L; Yang Z; Yu P; Song L; Gao Y; Gong M; Meng C; Shi H
    Neuroreport; 2020 Mar; 31(5):387-393. PubMed ID: 32106142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.